RecruitingPhase 3

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

China390 participantsStarted 2023-03-31

Plain-language summary

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who sign the informed consent form and are willing to complete the study according to the plan;
✓. Aged from 18 to 80 years old;
✓. ECOG equals 0 or 1;
✓. Not receiving lung cancer surgery before;
✓. Resectable peripheral cT1N0M0 tumors;
✓. Single lung nodules with ground-glass dominant or pure ground-glass on CT, or multiple lung nodules with the major lesion being the aforementioned nodules;
✓. Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
✓. Not receiving chemotherapy or radiotherapy before.

Exclusion criteria

✕. Not cT1N0M0;
✕. Cannot be completely resected by sublobar resection;
✕. Invasive lung adenocarcinoma or not lung adenocarcinoma diagnosed cytologically or pathologically;
✕. Receiving lung cancer surgery before;
✕. Receiving radiotherapy or chemotherapy.

What they're measuring

5-year recurrence-free survival

Timeframe: 5 years

Trial details

NCT IDNCT06031181

SponsorFudan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-01

Contact for this trial

Chaoqiang Deng

+86-13122677592 fdudengcq@163.com

View on ClinicalTrials.gov More Lung Adenocarcinoma trials